DCT

1:12-cv-08317

Endo Pharma Inc v. Impax Laboratories Inc

General

Filed

11/14/12

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (06/10/19)

Patent Owner

Operating Company (W)

PACER1:12-cv-08317

Appeals15-2021, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1060, 16-1117, 16-1118

CourtS.D. New York

Judge	Period	PO Win Rate
Thomas P. Griesa	--	63%

Plaintiff

Party

Name	Ratings
Endo Pharmaceuticals Inc	L5E
Grunenthal GmbH	L1C

Attorney

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5B
Basil J. Lewris	L5B
Joann M. Neth	L5C
Jennifer H. Roscetti	L4B
Sarah E. Craven	L4B
Anthony C. Tridico	L4C
Erin Sommers	L3B
Marianne S. Terrot	L3B
Matthew J. Luneack	L3C
Dechert LLP	L3C
Martin J. Black	L5A
Thomas P. Lihan	L5C
Robert D. Rhoad	L5C
Jonathan D. Loeb	L5C
Blake B. Greene	L4C
Sharon K. Gagliardi	L4E
Brian M. Goldberg	L3B
Joshua I. Sherman	L3C
Carl Gismervig	L3D
Jeffrey T. Fisher	L3D
Wilk Auslander LLPLocal	L1C
Stephen D. Hoffman	L1B
Eric B. Lamons	L1C

Defendant

Party

Name	Ratings
Impax Laboratories Inc	L4E
Impax Laboratories LLC	L4E
Thorx Laboratories Inc	---- --

Attorney

Name	Ratings
Winston & Strawn LLP	L5C
Scott R. Samay	L5B
George C. Lombardi	L5E
Maureen L. Rurka	L5E
Kevin E. Warner	L5E
Anna Lamut	L1D
Sara Gilloon	---- --